FDA approves new Alzheimer's treatment, donanemab from Eli Lilly
Branded as Kisunla by drugmaker Eli Lilly, donanemab's approval follows years of setbacks and delays in getting the ...
Las Vegas Sun1d
UNLV researcher optimistic as Alzheimer’s drug donanemab receives FDA approval
For Dr. Jeffrey Cummings, a brain health researcher and professor at UNLV, this is an exciting time in the fight against Alzheimer’s disease. Federal health advisers in May voted to ...
FDA approves Alzheimer’s drug donanemab after months of delay
The Food and Drug Administration granted approval Tuesday to a closely watched Alzheimer’s drug, concluding that the benefits ...
technologynetworks3d
New Alzheimer’s Drug Donanemab Approved by FDA
The drug donanemab (also known as Kisunla™) has been approved by the US Food and Drug Administration (FDA) for the treatment ...
Pharmaceutical Technology3d
FDA approves Eli Lilly’s Kisunla (donanemab) for early AD
GlobalData forecasts that Leqembi and Kisunla could generate global sales of approximately $3.5 billion and $2.0 billion ...
alzheimersnewstoday4d
FDA approves donanemab, now Kisunla, to treat early Alzheimer’s
Eli Lilly's donanemab, now Kisunla, was approved by the U.S. Food and Drug Administration for patients with early symptomatic ...
Alzheimer's Society4d
FDA approves new Alzheimer's disease drug donanemab in the US
Our Director of Research responds to news that the FDA has approved new Alzheimer's disease drug donanemab in the US.
Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease
The U.S. Food and Drug Administration (FDA) approved Kisunla™ (donanemab-azbt, 350 mg/20 mL once-monthly injection for IV ...
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease
The US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of ...
FDA Approves Eli Lilly’s Alzheimer’s Drug Donanemab
Eli Lilly’s donanemab—to be sold under the brand name Kisunla—received regulatory approval as a monthly injection after an 18 ...
FDA approves 'donanemab' treatment for Alzheimer's disease
The drug contains an antibody that aims to slow the progression of the incurable Alzheimer’s disease. It operates by ...
FDA approves Donanemab, new Eli Lilly treatment for early Alzheimer’s disease
A new treatment that could slow Alzheimer’s disease has been approved by the Food and Drug Administration. The drug Donanemab ...